Civik Thomas
Insider CIK 1723092 · FPRX President and CEO, Director · FMI Chief Commercial Officer · PYXS Interim CEO, Director · RPTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-09-04 | 2026-09-08 | 2,503,050 | — | $0 | 2,503,050 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-09-04 | 2026-09-08 | 2,503,050 | — | $0 | 2,503,050 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-08-12 | 2026-08-14 | 250,956 | — | $0 | 941,087 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-08-12 | 2026-08-14 | 250,956 | — | $0 | 941,087 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2026-02-03 | 2026-02-05 | 690,131 | — | $0 | 690,131 | SEC↗ |
| RPTX Repare Therapeutics Inc. | D To issuer | 2026-01-28 | 2026-01-28 | 7,500 | — | $0 | 0 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2025-03-31 | 2025-04-02 | 36,979 | $0.98 | $36.2K | 36,979 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2024-06-17 | 2024-06-20 | 27,200 | — | $0 | 27,200 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2024-03-26 | 2024-03-28 | 44,024 | $3.83 | $168.6K | 44,024 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 27,200 | — | $0 | 27,200 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2023-03-24 | 2023-03-28 | 139,355 | — | $0 | 206,186 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2022-05-13 | 2022-05-16 | 49,000 | — | $0 | 49,000 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award | 2022-03-31 | 2022-04-04 | 66,831 | — | $0 | 66,831 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | P Buy | 2021-11-18 | 2021-11-19 | 15,700 | $12.74 | $200.0K | 15,700 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2021-11-16 | 2021-11-18 | 7,500 | $28.08 | $210.6K | 7,500 | SEC↗ |
| PYXS Pyxis Oncology, Inc. | A Award deriv | 2021-10-07 | 2021-10-12 | 42,191 | — | $0 | 42,191 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2021-09-07 | 2021-09-09 | 42,000 | — | $0 | 42,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer deriv | 2021-04-16 | 2021-04-19 | 480,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | D To issuer | 2021-04-16 | 2021-04-19 | 68,971 | $38.00 | $2.62M | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | F Tax w/h | 2021-04-09 | 2021-04-13 | 11,088 | $37.94 | $420.7K | 68,971 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award deriv | 2020-04-13 | 2020-04-14 | 480,000 | — | $0 | 480,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS, I | A Award | 2020-04-13 | 2020-04-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| FMI Foundation Medicine, Inc. | J Other | 2018-07-31 | 2018-08-02 | 33,421 | $137.00 | $4.58M | 0 | SEC↗ |
| FMI Foundation Medicine, Inc. | A Award | 2018-01-01 | 2018-01-03 | 33,421 | $68.20 | $2.28M | 33,421 | SEC↗ |